# Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.

> **NCT03009422** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Leishmaniasis

## Interventions

- **DRUG:** Local application pentostam
- **DRUG:** intra-lisional pentostam
- **DEVICE:** fractional CO2 laser

## Key facts

- **NCT ID:** NCT03009422
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2017-02
- **Final completion:** 2017-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03009422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03009422, "Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03009422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*